Hello, Guest
Login
Sign Up
 
 

PennyStocks101 Reports 3 TOP Stocks to Watch Closely: Nike, Anacor Pharmaceuticals, and Eagle Bulk Shipping Inc.

PennyStocks101.com provides its subscribers with timely information and exclusive charts on cheap and under-valued stocks in the United States with the potential of breaking out.

 
 
Repost This

Beverly Hills, CA -- (SBWIRE) -- 03/22/2013 -- http://www.PennyStocks101.com - The US leader in microcap breakouts, offers a high quality stocks alert newsletter to investors looking for the best breakout stocks around. PennyStocks101 reports 3 penny stocks to keep an eye on for a possible bounce or more gains: NKE, ANAC, and EGLE

The market rebounded on Friday with the help of strong earnings from Major U.S. corporations like Nike who hit a new record. The Dow Jones average rose 92 points in midday trading, The Standard & Poor's 500 index rose 10 points, and the Nasdaq composite rose 16 points.

1. Nike (NYSE: NKE) - Nike, Inc.'s principal business activity involves the design, development and worldwide marketing of high quality footwear, apparel, equipment, and accessory products.

2. Anacor Pharmaceuticals (Nasdaq: ANAC) - Anacor Pharmaceuticals, Inc. is a biopharmaceutical company engaged in discovery, development and commercialization of novel small-molecule therapeutics derived from its boron chemistry platform.

3. Eagle Bulk Shipping Inc. (Nasdaq: EGLE) - Eagle Bulk Shipping is the largest U.S. based owner of Handymax dry bulk vessels.

PennyStocks101.com educates and shows investors the inner workings of the volatile world of penny stocks by scouring the markets for the hottest penny stocks that look poised to break out. Discover the next hidden company to profit. Sign up for the free newsletter to receive the next big report soon. Join at: http://www.PennyStocks101.com

Sign Up at - http://www.PennyStocks101.com for more ideas to put on your radar.

Disclosure
PennyStocks101.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. This press release may contain several forward looking statements. Please read our report and visit our website for complete risks and disclosures.